awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34022596-10846D0C-3C86-4006-BD77-75F4F7B85ED1
Q34022596-10846D0C-3C86-4006-BD77-75F4F7B85ED1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34022596-10846D0C-3C86-4006-BD77-75F4F7B85ED1
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.
P2860
Q34022596-10846D0C-3C86-4006-BD77-75F4F7B85ED1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34022596-10846D0C-3C86-4006-BD77-75F4F7B85ED1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a71db1d8f5264a99f3bef95f0d3bd1737b0f77c
P2860
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)